InvestorsHub Logo

justdafactss

03/01/24 9:51 AM

#230433 RE: kgromax #230431

To make a long story short, it seems theyre hiding something. That about sum it up?

If so, I agree.

Whaaaah? No questions in the upcoming call? I smell a rat.

justdafactss

03/02/24 12:28 PM

#230479 RE: kgromax #230431

Removing pieces one by one until the FDA says yes.--- Yes kgro, I believe once again youve hit the nail squarely on the head.

Both the PR and yesterdays 424B3 filing failed to specifically mention the words "the newly proposed clinical trial protocol submitted in November 2023".

The November 2023 protocol was a no can do with the FDA---

The FDA notified the Company at the beginning of December 2023 that: (i) the FDA’s “partial hold” imposed in March 2022 had been lifted; and (ii) a new “full hold” had been applied related to the clinical trial protocol the Company submitted in November 2023 alongside the Company’s complete response to the partial clinical hold. The Company submitted a revised protocol to the FDA in January 2024, and will remain on clinical hold until the FDA clears the protocol.
https://www.sec.gov/Archives/edgar/data/1175680/000155837024001547/cydy-20240130x424b3.htm

Looking like the v.January 2024 didnt take either, somewhere a "softened up" version limped across the finish line.

Good call.